Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion

被引：34
|
作者：
Whelan, Bryan R. [1 ]
Isenberg, David A. [1 ]
机构：
[1] UCL, Ctr Rheumatol, London W1T 4JF, England
来源：
RHEUMATOLOGY | 2009年 / 48卷 / 05期
关键词：
SIGNAL RECOGNITION PARTICLE; RITUXIMAB; AUTOANTIBODIES; ANTIBODIES; MYOPATHY; THERAPY;
D O I：
10.1093/rheumatology/kep027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：594 / 595
页数：2
相关论文
共 50 条
  • [1] Clinical features and therapeutic response of our anti-SRP positive patients with myositis
    Balazs, Botos
    Melinda, Nagy-Vincze
    Katalin, Danko
    ORVOSI HETILAP, 2017, 158 (35) : 1382 - 1389
  • [2] B-cell depletion in immune thrombocytopenia
    Psaila, Bethan
    Cooper, Nichola
    LANCET, 2015, 385 (9978) : 1599 - 1601
  • [3] B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
    Herbst, Ronald
    Wang, Yue
    Gallagher, Sandra
    Mittereder, Nanette
    Kuta, Ellen
    Damschroder, Melissa
    Woods, Rob
    Rowe, Daniel C.
    Cheng, Li
    Cook, Kim
    Evans, Krista
    Sims, Gary P.
    Pfarr, David S.
    Bowen, Michael A.
    Dall'Aqua, William
    Shlomchik, Mark
    Tedder, Thomas F.
    Kiener, Peter
    Jallal, Bahija
    Wu, Herren
    Coyle, Anthony J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (01) : 213 - 222
  • [4] Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis
    Moeller, Burkhard
    Aeberli, Daniel
    Eggli, Stefan
    Fuhrer, Martin
    Vajtai, Istvan
    Voegelin, Esther
    Ziswiler, Hans-Rudolf
    Dahinden, Clemens A.
    Villiger, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03)
  • [5] B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia
    Zaja, F
    Iacona, I
    Masolini, P
    Russo, D
    Sperotto, A
    Prosdocimo, S
    Patriarca, F
    Regazzi, M
    Baccarani, M
    Fanin, R
    de Vita, S
    HAEMATOLOGICA, 2002, 87 (02) : 189 - 195
  • [6] Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab
    Aggarwal, Rohit
    Oddis, Chester V.
    Goudeau, Danielle
    Koontz, Diane
    Qi, Zengbiao
    Reed, Ann M.
    Ascherman, Dana P.
    Levesque, Marc C.
    RHEUMATOLOGY, 2016, 55 (06) : 991 - 999
  • [7] The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
    Cooper, N
    Stasi, R
    Cunningham-Rundles, SS
    Feuerstein, MA
    Leonard, JP
    Amadori, S
    Bussel, JB
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 232 - 239
  • [8] Immune regulation and B-cell depletion therapy in patients with primary Sjogren's syndrome
    Abdulahad, Wayel H.
    Kroese, Frans G. M.
    Vissink, Arjan
    Bootsma, Hendrika
    JOURNAL OF AUTOIMMUNITY, 2012, 39 (1-2) : 103 - 111
  • [9] Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
    da Costa, Rita Quelhas
    Elena Aguirre-Alastuey, M.
    Isenberg, David A.
    Saracino, Amanda M.
    JAMA DERMATOLOGY, 2018, 154 (12) : 1432 - 1440
  • [10] Depletion of B cells rejuvenates the peripheral B-cell compartment but is insufficient to restore immune competence in aging
    Avivi, Irit
    Zisman-Rozen, Simona
    Naor, Shulamit
    Dai, Isabelle
    Benhamou, David
    Shahaf, Gitit
    Tabibian-Keissar, Hilla
    Rosenthal, Noemie
    Rakovsky, Aviya
    Hanna, Ammuri
    Shechter, Arik
    Peled, Eli
    Benyamini, Noam
    Dmitrukha, Ekaterina
    Barshack, Iris
    Mehr, Ramit
    Melamed, Doron
    AGING CELL, 2019, 18 (04)
12345